Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (797) Hepsera (adefovir dipivoxil), Gilead,
...Newly Approved Drug Therapies (797) Hepsera (adefovir dipivoxil), Gilead, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Hepsera (adefovir dipivoxil) Company: Gilead Approval Status: Approved September 2002 Treatment Area: Chronic Hepatitis B General Information ...
View Page

2.  Study Posting (4519) Trial #156285, Hepatitis B, Taoyuan, Taiwan
...Taoyuan, Taiwan Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B Status: Recruiting Protocol Number: ML21827 ...
...open-label study of the effect of peginterferon alfa-2a (40KD)(PEGASYS) in combination with Adefovir or Entecavir on HBeAg seroconversion in patients with HBeAg positive chronic hepatitis B Brief Summary ...
View Page

3.  Study Posting (4519) Trial #156156, Hepatitis B, Taipei, Taiwan
...Taipei, Taiwan Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B Status: Recruiting Protocol Number: ML21827 ...
...open-label study of the effect of peginterferon alfa-2a (40KD)(PEGASYS) in combination with Adefovir or Entecavir on HBeAg seroconversion in patients with HBeAg positive chronic hepatitis B Brief Summary ...
View Page

4.  Study Posting (4519) Trial #156155, Hepatitis B, Taichung, Taiwan
...Taichung, Taiwan Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B Status: Recruiting Protocol Number: ML21827 ...
...open-label study of the effect of peginterferon alfa-2a (40KD)(PEGASYS) in combination with Adefovir or Entecavir on HBeAg seroconversion in patients with HBeAg positive chronic hepatitis B Brief Summary ...
View Page

5.  Study Posting (4519) Trial #156154, Hepatitis B, Kaohsiung, Taiwan
...Kaohsiung, Taiwan Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B Status: Recruiting Protocol Number: ML21827 ...
...open-label study of the effect of peginterferon alfa-2a (40KD)(PEGASYS) in combination with Adefovir or Entecavir on HBeAg seroconversion in patients with HBeAg positive chronic hepatitis B Brief Summary ...
View Page

6.  Study Posting (4519) Trial #156256, Hepatitis B, Changhua, Taiwan
...Changhua, Taiwan Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B Status: Recruiting Protocol Number: ML21827 ...
...open-label study of the effect of peginterferon alfa-2a (40KD)(PEGASYS) in combination with Adefovir or Entecavir on HBeAg seroconversion in patients with HBeAg positive chronic hepatitis B Brief Summary ...
View Page

7.  Study Posting (2348) Trial #149983, Hepatitis B, New York, NY
...Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naive Patients with HBeAg Positive Chronic Hepatitis ...
...this study is to compare the safety and effectiveness of the study medication clevudine to adefovir dipivoxil (Hespera) in people who have HBV and who have never been treated with hepatitis ...
View Page

8.  Study Posting (4519) Trial #134002, Hepatitis B, Gaziantep, Turkey
...B, Gaziantep, Turkey Trial Information ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B Status: Recruiting Protocol Number: ML20622 Sponsor: Hoffmann ...
...Title: A randomized, open label study to compare the effect of combination treatment with PEGASYS + adefovir dipivoxil versus PEGASYS monotherapy on HBV-DNA and ALT levels in patients with HBeAg-negative ...
View Page

9.  Study Posting (4519) Trial #134001, Hepatitis B, Ankara, Turkey
...B, Ankara, Turkey Trial Information ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B Status: Recruiting Protocol Number: ML20622 Sponsor: Hoffmann ...
...Title: A randomized, open label study to compare the effect of combination treatment with PEGASYS + adefovir dipivoxil versus PEGASYS monotherapy on HBV-DNA and ALT levels in patients with HBeAg-negative ...
View Page

10.  Study Posting (2348) Trial #80979, Hepatitis, New York, NY
...New York, NY Trial Information A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil for the Treatment of Presumed Pre-core Mutant Chronic Hepatitis B [GS-US-174 ...
...is to compare the safety and the effectiveness of tenofovir DF (TDF) to that of adefovir dipivoxil (ADV) in patients chronically infected with HBV who have never taken an oral treatment ...
View Page

11.  Study Posting (4519) Trial #147411, Hepatitis B, Villejuif, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

12.  Study Posting (4519) Trial #147409, Hepatitis B, Toulouse, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

13.  Study Posting (4519) Trial #125793, Hepatitis B, Saint Laurent Du Var, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

14.  Study Posting (4519) Trial #147854, Hepatitis B, Pessac, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

15.  Study Posting (4519) Trial #123013, Hepatitis B, Paris, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

16.  Study Posting (4519) Trial #124064, Hepatitis B, Orleans, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

17.  Study Posting (4519) Trial #147402, Hepatitis B, Montpellier, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

18.  Study Posting (4519) Trial #147398, Hepatitis B, Marseille, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

19.  Study Posting (4519) Trial #147392, Hepatitis B, Lille, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page

20.  Study Posting (4519) Trial #147388, Hepatitis B, Grenoble, France
...study to compare the effect of new-onset therapy with PEGASYS, and continuation therapy with adefovir dipivoxil or lamivudine, on viral response in patients with chronic hepatitis B pre-treated with adefovir dipivoxil or lamivudine. Brief Summary: This study will compare the efficacy and safety of PEGASYS ...
View Page